Leigh MacMillan

May 8, 2024

Supercomputing redesign of a COVID monoclonal antibody

The approach, which combines high-performance computing, simulation, machine learning and experimental validation, will help keep antibody drugs up to date in the future against highly variable viruses.

By Leigh MacMillan
April 30, 2024

Atherosclerosis is a tumor-like disease: study

An anticancer drug blunted atherosclerosis progression — and even made plaques shrink — in a mouse model of the disease, opening new opportunities for preventing and treating this leading cause of death.

By Leigh MacMillan
Mariana Byndloss, DVM, PhD
April 15, 2024

Mariana Byndloss receives FASEB Excellence in Science Award

The annual awards highlight outstanding achievements by women in the biological sciences.

By Leigh MacMillan
April 5, 2024

VandyWorks migration, renaming and downtime begins on April 12

April 5, 2024

Monroe Carell “Time for Remembering” is April 21

April 5, 2024

Library changes on April 15

April 5, 2024

Institute of Chemical Biology seminar by Indiana’s Steven Johnson is April 11 

April 5, 2024

Update: End of influenza masking period for exempted unvaccinated VUMC faculty and staff 

March 7, 2024

Study details metabolism of biomarkers for oxidative stress

Factors other than oxidative stress can modify the levels of biomarkers called isoprostanes that are commonly used in both experimental and clinical research, suggesting that additional standards need to be developed.
By Leigh MacMillan
February 27, 2024

Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment

Multi-institutional study finds that enrollment and outcomes were similar across various groups of children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.
By Leigh MacMillan
February 21, 2024

International genetic study of glaucoma implicates vascular and cancer-related genes

An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.
By Leigh MacMillan
February 20, 2024

Liver disease specialist Ashley Spann receives two career development awards

Vanderbilt's Ashley Spann, MD, MSACI, is the inaugural recipient of the Harold Amos Medical Faculty Development Program Hepatology Award from the American Association for the Study of Liver Diseases.
By Leigh MacMillan